Non-Convulsive Status Epilepticus (NCSE) in ICU by Wiryana, Made et al.
REVIEW ARTICLE
Bali Journal of Anesthesiology (BJOA) 2017, Volume 1, Number 1: 20-24
E-ISSN: 2549-2276
20 Open access: www.bjoa.balijournals.org
CrossMark
Published by DiscoverSys
1Professor, 2-7Senior Lecturer, 
8-9Resident, Department of 
Anesthesiology, Pain Management 
and Intensive Care, Udayana 
University, Sanglah General 
Hospital, Denpasar-Bali, Indonesia
*Correspondence to: Dr. Christopher 
Ryalino, Resident of Anesthesiology, 
Pain Management and Intensive 
Care, Udayana University, Sanglah 
General Hospital, Kesehatan Street 
No 1, Denpasar-Bali, Indonesia 
Ph/Fax: +62 361 257361/235980 
anesthesiology@unud.ac.id
ABSTRACT
Epilepsy is a neurological disorder characterized by recurrent epileptic 
seizures. Non-convulsive status epilepticus (NCSE) is defined as a persistent 
change in mental status as opposed to the previous conditions, lasted at 
least 30 minutes long, associated with continuous spike wave epileptiform 
EEG changes. Clinical manifestation of NCSE can present as confusion, 
personality changes, psychosis, and coma. Indeed NCSE prognosis 
is dependent on the underlying etiology of persistent EEG changes. 
Preferred medication is focus on improving its fundamental pathological 
changes, such as metabolic disorders, infection, drugs toxicity, and 
immediate pharmacological treatment. Intravenous benzodiazepine is 
recommended as the first drug of choice for NCSE and early recognition of 
treatment response can help to establish the diagnosis. This patient has 
a good outcome which was influenced with short ictal period from the 
first episode upon arrival on reffered hospital, good initial response and 
management on emergency department, a conduct and thorough ICU 
monitoring, as well as the effective treatment response.
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INTRODUCTION
Epilepsy is a brain abnormality characterized by 
recurrent epileptic seizure (more than one episode). 
Epilepsy is a brain disorder characterized by the 
 presence of predisposing factors that can trigger 
epileptic seizures, changes in the neurobiological, 
cognitive, psychological, and social consequences.1
Non-convulsive status epilepticus (NCSE) is 
an altered mental status from previous condition, 
lasted at least 30 minutes, associated with  continued 
peaks on EEG. Clinical manifestations can vary 
from confuse state to bizarre behavior disorders and 
psychosis and coma. NCSE is often undiagnosed, 
and often also considered as a psychiatric disorder.2
Prognosis of NCSE depends on the underlying 
disease which cause persistent peak seizure on EEG. 
Treatment aims mainly to correct the fundamental 
pathological changes, such as metabolic disorders, 
infections, drug toxicity and immediately initiate 
pharmacological treatment. Giving intravenous 
benzodiazepines is the first option for NCSE and 
the treatment response may help to confirms the 
diagnosis. Lorazepam with a dose of 0.05-0.1 mg/g 
is the best choice from benzodiazepines.1,3
DEFINITION
Epilepsy occurs because the local electrical 
impulse on brain gray matter that occur at any 
time, suddenly, and very quickly which can cause 
decrease of consciousness, changes on motor or 
sensory function, intermittent and stereotipic 
behavioral or emotion.1 Release of abnormal elec-
trical  activity from neurons in the brain occurs 
because of impaired function of neuronal cells. 
Disturbance in this function can be found as distur-
bances in physiological, biochemical, anatomical 
with both local and general manifestations.
Epilepsy is a brain disorder characterized by 
recurrent epileptic seizures (more than one episode). 
International League Against Epilepsy (ILAE) and 
the International Bureau for Epilepsy (IBE) in 2005 
redefined the definition of epilepsy which is a brain 
disorder characterized by the presence of predis-
posing factors that can trigger epileptic seizures, 
changes in the neurobiological, cognitive, psycho-
logical, and its social consequences. This definition 
requires at least one previous history of epileptic 
seizures.4
Non-convulsive epileptic seizure is an epileptic 
seizure that lasts more than 30 minutes marked by 
a continuous seizure activity or repeated changes 
electroencephalogram (EEG), which causes a 
variety of clinical symptoms include impaired 
consciousness, perception disorders with abnormal 
behavior.
According to The Epilepsy Research Foundation 
non-convulsive status epilepticus is series of condi-
tions where was found extending seizure activity 
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that causes non-convulsive manifestations. When a 
child is suspected of having non-convulsive status 
epilepticus, the EEG should be done immediately. 
EEG recordings will be easier for the doctor to 
confirm the diagnosis or exclude the diagnosis of 
non-convulsive status epilepticus. Ideally, EEG 
performed before the child received anti-epileptic 
drugs. EEG is also useful for monitoring treatment 
response.4
Non-convulsive status epilepticus is distin-
guished with convulsive status epilepticus because 
no or little discovery of motoric components. The 
dominant sign of status non-convulsive status 
epilepticus is altered mental status associated with 
the changes in EEG.
ETIOLOGY
Epilepsy is a chronic neurological disease char-
acterized by unprovoked recurrent seizure that. 
The cause is electrical impulse disorder of neural 
networks that are not well-controlled in some parts 
or whole parts of the brain. Disruption of brain 
function that can cause excessive release of elec-
trical charge on the central nervous neuronal cells, 
could be caused by physiological factors, biochemi-
cal, anatomical, or a combination of these factors.1,3
Each diseases or disorders that may interfere 
brain function or the function of neurons in the 
brain, can cause seizures or epileptic attack. To 
define the causative factor can be determined by 
looking at the age when the first attack occured. 
For example, age under 18 years is likely caused by 
perinatal trauma, febrile seizures, inflammation of 
the central nervous system, structural, metabolic 
diseases, toxic circumstances, systemic disease, 
head trauma diseases, and others.1,4
Seizures can also be caused by a variety of disor-
ders and illnesses of which are birth trauma, head 
injury, brain inflammation, brain tumors, brain 
bleeding, circulatory disorders, hypoxia, congenital 
anomalies of the brain, degenerative disorders of 
the central nervous system, metabolic disorders, 
disorder electrolytes, fever, toxic-allergic reactions, 
drug or chemical poisoning, and heredity.
Various precipitating factors may be involved 
in the NCSE including metabolic disorders, 
infections, intoxication, alcohol, pregnancy, drug 
intoxication, such as amitriptyline, theophylline, 
cephalosporin, chemotherapeutic drug, withdrawal 
of  anti-epileptic and carbamazepine, very rarely 
lamotrigine, phenobarbital, and phenytoin.4
EPIDEMIOLOGY
According to the Epilepsy Foundation 
Research, NCSE estimated incidence rate of 
6-18/100,000 cases/year. Towne et al, in a prospec-
tive study of 236 patients with coma which is not 
found seizures clinically, reported 8% of the patients 
met the criteria of NCSE on EEG. De Lorenzo et al 
acquired the 14% of the patients who review after 
receiving GCSE. Privitera and Strawburg reported 
on a prospective study found out on 198 patients 
with altered level of consciousness in the EEG was 
found NCSE. NSCE was reported can be found at 
any age from the very young to very old, both sexes 
without distinction.4
In adults, NCSE estimated happens in quarter 
of all cases of status epilepticus. Data for NCSE 
in children is rarely reported due to the lack of 
consensus on the diagnosis and mainly because of 
not knowing the symptoms as a disorder or patho-
logic disorder or misinterpretation as a behavioral 
problem.
Classification of Epilepsy4
A. Partial / Focal Seizure
1. Simple partial seizure (without altered 
consciousness)
 a. With motoric symptom
 b. With sensoric symptom
 c. With otonomic symptom
2. With psychological manifestation
 a.  Complex partial seizure (with conscious-
ness disturbance)
 b.  Simple partial seizure at the beginning, 
followed with consciousness disturbance
3. With alteration of conciousness from the 
beginning of seizure
 a.  Secondary generalized seizure 
 (tonic-clonic, tonic or clonic)
 b.  Simple partial seizure developed to 
 generalized seizure
 c.  Complex partial seizure developed to 
generalized seizure
 d.  Simple partial seizure developed 
to complex partial, and then developed to 
generalized seizure
B.  Generalized Seizure (Convulsive or 
Non-Convulsive)
1. Lena seizure (absence): Lena attack was char-
acterized by short duration, sudden onset and 
termination, often in frequency, sometimes 
accompanied by clonic movement on eyes, 
chin, and lips.
2. Mioclonic seizure: mioclonic seizure is a 
sudden contraction, rapid, and could be gener-
alized or limited on facial area, torso, one or 
more extremities, or one muscle group. Can be 
repeated or single attack.
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3. Tonic seizures: rigid muscle contraction, 
 causing the limbs settled in one position. 
Usually there is deviation of the eyeball and 
head to one side, can be accompanied by the 
rotation of the entire torso. The face becomes 
pale and then red and bluish because unable 
to breathe. Eyes open or closed, conjunctiva 
become insensitive, and pupil dilatation.
4. Atonic seizure: Represent as lose of muscle 
tone. Can occur fragmentally, only head fall 
forward or the arm drop in hanging position, 
or generalized so that patient can fall.
5. Clonic seizure: This type of seizure has no tonic 
component, only clonic seizure will happen, 
found mainly on children.
6. Tonic-Clonic Seizure: Seizure which is started 
with tonic seizure, and followed with clonic 
movement.
PATOPHYSIOLOGY
Neurons have a membrane potential, this occurs 
because of the difference in ions charge inside and 
outside the neuron. Differences in the amount 
of the charge of these ions cause polarization of 
the membrane with intraneuron part is more 
negative. Neuron synapsed with other neurons 
through axons and dendrites. An excitation input 
via synapses will cause membrane depolarization 
which happened in short duration, then inhi-
bition would lead to hyperpolarization of the 
membrane.
When excitation is quite large and inhibition is 
small, axon begin stimulated, an action potential is 
sent along the axon, to stimulate or inhibit other 
neurons, so epilepsy will happen.
CLINICAL MANIFESTATION
Clinical manifestation of NCSE includes a  thorough 
mental status changes. It can be acknowledge by 
family or friends, can be found as delirium or coma 
state. Fluctuation of symptoms can occur at various 
levels, so can obscure the diagnosis.3,5
Motoric activity is normal in most cases, some-
times found stiffness (clumsiness), apraxia, focal 
Table 1 Status Epilepticus Management in ICU1
Critical care treatment
Timing (minutes post seizure 
onset) Goals
Non-invasive airway protection anti £as exchange 
with head positioning
Immediate (0-2 min) Maintain airway patency, avoid snoring, 
administer O2
Intubation (if airway/gas exchange compromised  
or elevated ICP suspected)
Immediate (0-10 min> Establish secure oxygenation and ventilation
Vital signs: O2 saturation, BP, HR Immediate (0-2 min) Establish and support baseline vital signs
Vasopressor support of BP if SBP <90 mmHg or 
MAP <70
Immediate (5-15 min) Support CPP
Finder stick blood glucose Immediate (0-2 min) Diagnose hypoglycemia
Peripheral IV access Immediate (0-5 min) Establish medication route
1.  Emergent initial AED therapy  
(i.e. benzodiazepine}
1. Stop seizure
2. Fluid resuscitation 2. Establish euvolemia
3.  Nutrient resuscitation (thiamine given  
before dextrose; dextrose}
3.  Reverse thiamine deficiency, treat 
hypoglycemia
Urgent SE control therapy with AED Immediate after initial AED given  
(5-10 min)
Stop seizure
Neurologic exam Urgent (5-10 min) Evaluate for mass lesion, acute intracranial process
Triage lab test panel (see Table 2) Immediate (5 min) Diagnose life threatening metabolic condition
Refractory SE treatment Urgent (20-60 min after 2nd AED) Stop seizures; treatment strategies based 
on individual patient response and AED 
concentrations (if applicable)
Urinary catheter Urgent (O-60 min) Evaluate systemic circulation
Continuous EEG Urgent (15-60 min) Evaluate for NCSE if not waking up after clinically 
obvious seizures cease
Diagnostic testing (selection depends on  
clinical presentation)
Urgent (O-60 min) Evaluate for mass lesions, meningitis, encephalitis
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jerking, twiching of facial muscles (blinking eyes), 
chewing movement, automatism movement in the 
form of real motion is very rare, such as flexion, 
extension of extremity, deviation of the head.5
Other symptoms can include mild cognition 
impairment (attention disorder), difficulty in plan-
ning of regular and complex motoric movement 
(sequentially), minor disorientation or confusion, 
prolonged confusional state, mood disorders, 
speech disorders (speech not fluently, aphasia, 
silent), psychotic symptoms, autonomic disor-
ders (belching, rumbling in the stomach, flatus), 
sensory disturbances, loss of consciousness, and 
coma.3,4,5
TREATMENT
Although there are a lot of controversy about when 
to begin treatment of NCSE, the general principle 
of treatment for NCSE is as soon as possible to get 
the etiology and trigger factors and treat as soon 
as possible the trigger factor of physiologic stress 
including infections, toxic metabolic disorders, 
drug interactions or withdrawal and pregnancy.4
Administration of intravenous benzodiazepines 
should be done with EEG monitoring. Diagnostic 
confirmation with EEG is required before pharma-
cological treatment is given. Reportedly, in some 
cases has a response immediately after administra-
tion of intravenous benzodiazepines.1
Although there is sometimes a tendency of 
NCSE for recurring and necessary to grant addi-
tional anticonvulsants. Benzodiazepines such as 
diazepam, lorazepam, clonazepam, and midazolam 
can be given as monotherapy or in combination. 
The response of the NCSE to benzodiazepines, 
sometimes slow, or followed by a recurrence of 
symptoms several hours or days later, the grant-
ing of long-acting anti-epileptic may be required. 
Provision of benzodiazepines should be cautious 
in patients contained numerous medical problems 
where hypotension and respiratory depression 
could occur.1,6
When the diagnosis of NCSE has been 
confirmed, and seizures have been controlled, long-
term medication treatment should be considered. 
There are a wide range of antiepileptic drugs such 
as phenitoin, valproic acid, and phenobarbital can 
be administered intravenously to acute phase and 
orally for long-term treatment.5
Carbamazepine, Phenytoin and a new gener-
ation of anti-epileptic (lamotrigine, topiramate, 
Table 2 Drugs dosing used in refractory status epilepticus in ICU1
Drug Initial dose
Continuous infusion dosing 
recommendations-titrated to EEG
Serious adverse 
effects Considerations
Midazolam 0.2 mg/kg; administer 
at an infusion rate of 
2 mg/m in
0.05-2 mg/kg/hr Cl 
Breakthrough SE: 0.1-0.2 mg/kg bolus, 
increase Cl rate by 0.05-0.1 mg/kg/hr  
every 3-4 h
Respiratory depression 
Hypotension
Tachyphylaxis occurs after 
prolonged use
Active metabolite, 
renally eliminated, rapid 
redistribution (short 
duration), does NOT 
contain propylene glycol
Pentobarbital 5-15 mg/kg, may 
give additional 
5-10 mg/kg; 
administer at 
an infusion rate 
≤50 mg/min
0.5-5 mg/kg/h Cl
Breakthrough SE: 5 mg/kg bolus,  
increase Cl rate by 0.5-1 mg/kg/h every  
12 h
Hypotension, respiratory 
depression, cardiac 
depression, paralytic 
ileus, at high doses - 
complete loss of 
neurological function
Requires mechanical 
ventilation 
IV contains propylene 
glycol
Propofol Start at 20 mcg/kg/
min, with 1-2 mg/kg 
loading dose
30-200 mcg/kg/min Cl Use caution when 
administering high doses (>80 mcg/kg/min) 
for extended periods of time (i.e., >48 h) 
Peds: Use caution with doses >65 mcg/kg/min: 
contraindicated in young children 
Breakthrough SE: Increase Cl rate by 
5-10 mcg/kg/min every 5 min or  
1 mg/kg bolus phis Cl titration
Hypotension (especially 
with loading dose in 
critically ill patients), 
respiratory depression, 
cardiac failure, 
rhabdomyolysis, 
metabolic acidosis, renal 
failure (PRIS)
Requires mechanical 
ventilation
Must adjust daily caloric 
intake (1.1 kcal/ml)
Thiopental 2-7 mg/kg, administer 
at an infusion rate  
≤50 mg/min
0.5-5 mg/kg/h CT Breakthrough SE:  
1-2 mg/kg bolus, increase Cl rate by  
0.5-1 mg/kg/h every 12 h
Hypotension, respiratory 
depression, cardiac 
depression
Requires mechanical 
ventilation
Metabolized to 
pentobarbital
Cl continuous infusion; EEG electroencephalogram; h hour; IM intramuscular; IV intravenous;IVP intravenous push: min minute; PRIS propofol related infusion.
syndrome
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levetirocetam) can be considered as a long-term 
treatment. Valproic acid is the drug of choice 
for epilepsy absence, and clonazepam can 
also be used. Vigabatrin and Tiagabine is not 
recommended for allegedly holding role for the 
 occurrence of exacerbations and precipitating 
factors of NCSE.6
Meanwhile in the ICU, the management of status 
epilepticus include a broad spectrum management 
ranging from securing the airway to the giving of 
sedative drugs.
In cases where there is a refractory status epilep-
ticus, some drugs such as midazolam, propofol, 
pentobarbital and thiopental in accordance with 
the recommended dose contained in Table 2.
CONCLUSION
According to The Epilepsy Research Foundation, 
nonconvulsive status epilepticus is a term used 
to denote a range of conditions in which electro-
graphic seizure activity is prolonged and results 
in nonconvulsive clinical symptoms The clinical 
presentation of patients supports the definition of 
status epilepticus NCSE which the symptom that 
appears is elongated period of unconscious patient 
without repeated seizure during treatment.1,3 
Initial treatment performed in the ER and ICU 
is to maintain patency of the airway and provide 
oxygen supplementation, application of access 
intravenous fluids, assessment of vital signs includ-
ing blood sugar tests, catheter urine, administra-
tion of drugs known as benzodiazepines to control 
seizure activity that occurs in the ER, laboratory 
tests to exclude other causes of extracranial, and a 
CT scan to rule out the possibility of intracranial 
lesions.6 
In patients with loss of consciousness, enteral and 
intravenous nutritional therapy and are absolutely 
necessary. In these patients, the caloric needs can be 
fulfilled from enteral feeding, and since the patient 
regain his consciousness, patient can eat and drink 
as usual. Paracetamol is given as an analgesic, and 
may also serve to handle fever, where the fever can 
also trigger seizures. Omeprazole given for peptic 
ulcer prophylaxis in hospitalized patients with crit-
ical illness
Outcome of patients have either influenced 
from short duration ranging from first seizure until 
arrival at the referral hospital, initial treatment in 
the ER, ICU monitoring conducted in, as well as the 
course of the disease that is responsive to medica-
tion given. 
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